Bionano Genomics is acquiring genomics software firm BioDiscovery in a $90 million cash and stock deal. While both companies provide genomics analysis solutions, Bionano said combining its technology with BioDiscovery’s software will provide the integrated offering that many labs want.
Mergers and Acquisitions
Amicus Therapeutics is spinning its gene therapy pipeline into a separate entity that will go public via a SPAC merger. Executives say the transaction puts Amicus on a path to profitability while simultaneously securing the cash needed to develop the gene therapy assets.
Walgreens bought a 71% stake in Shields Health Solutions, which strikes partnerships with hospitals to run specialty pharmacy programs. Walgreens has the option to buy the remaining equity interests in the future.
Combining the two companies would allow patients to access genetic testing and their health records in one place, and make it easier for Invitae to collect and organize health records.
The two companies will merge to form Headspace Health, which will combine Headspace’s many meditation and wellness exercises with Ginger’s coaching and therapy services. The combined company will have more than 800 employees and a $3 billion valuation.
The company is buying two urgent care chains in Tuscon, Arizona and Sacramento, California. It now has 83 clinics in 12 states, as it looks to go toe-to-toe with other primary care competitors.
A consortium of investors, led by Nordic Capital and Insight Partners, plan to acquire the company in a deal that would value it at $7.3 billion. It’s expected to close later this year or in early 2022.
HCA plans to sell PatientKeeper, which makes physician workflow software, to health IT startup Commure. The hospital chain will get a minority stake in the combined company.
Verily’s recent moves have signaled the company’s interest in supporting decentralized clinical trials and real-world studies. Now the life sciences subsidiary of Alphabet is bolstering its capabilities in this these areas with the acquisition of startup SignalPath.
The US-based company continues its move away from smoking products with the purchase of drug developer OtiTopic, as part of its Beyond Nicotine initiative.
Amgen is paying $900 million up front to acquire Teneobio, a biotech with technology for discovering and developing antibody drugs. Though Amgen already has its own antibody platform, the company says Teneobio’s technology and drug assets will complement its own.
An expert speaking at a scheduled roundtable offers a glimpse of the session, focused on the flurry of deal-making in recent months, and what lies ahead.
The past several days have seen a relatively large number of industry acqusitions, with Lilly, Phillip Morris, WCG, CTI and others making notable buys.
Tobacco company strikes deal for British firm developing pioneering inhaled treatment for Covid-19 Coronavirus – latest updates See all our coronavirus coverage Philip Morris International, the tobacco company and maker of Marlboro cigarettes, has struck a £1bn deal to buy Vectura, the British pharmaceutical company developing a pioneering inhaled treatment for Covid-19. The £1.04bn offer …
Valo Health is going public in a SPAC merger. Less than nine months removed from its formal launch, Valo is now revealing more about its artificial intelligence platform technology, which it plans to use to make the firm the first “digitally native” pharmaceutical company.
MorphoSys is acquiring Constellation Pharmaceuticals and its late-stage myelofibrosis drug in a deal that values the epigenetics biotech at $1.7 billion. Germany-based MorphoSys will finance the acquisition with cash from a separate $2 billion deal with drug royalty acquirer Royalty Pharma.
This monthâs roundup of hires, acquisitions, anniversaries, and other announcements includes news from Premier Research, Cytel, ACG, and other companies.
Private equity firm Carlyle Group to buy company that is developing inhaled treatment for Covid-19 Coronavirus – latest updates See all our coronavirus coverage The British pharmaceutical company Vectura Group, which is developing a pioneering inhaled treatment for Covid-19, has agreed a £958m takeover by Carlyle Group as it looks set to become the latest …
Healthcare payments startup Cedar acquired another billing startup, OODA Health, for $425 million. The deal would bring together billing tools for providers and payer onto one platform.
Covid crisis spurs growing interest in drugmakers, diagnostics and medical equipment firms UK drugmakers, diagnostics, medical equipment and other life sciences companies have raised £10.6bn from private funding rounds and stock market flotations in the first three months of the year, more than half of last year’s record total, according to a report. Last year, …
Amplyx Pharmaceuticals brings Pfizer a clinical-stage antifungal candidate with a novel mechanism of action. The pharmaceutical giant is trying to build its antifungal product lineup, which is currently led by a drug that has lost patent protection.
Relay Therapeutics has its own technology that applies artificial intelligence and machine learning techniques to drug discovery. Its $85 million acquisition of ZebiAI gives it another technology that applies ML to DNA-encoded libraries and predicts the small molecules with the potential to drug proteins.
Thermo Fisher Scientific sells laboratory equipment used in drug research and it also offers manufacturing services for experimental and commercialized drugs. By acquiring PPD, Thermo Fisher says it will gain capabilities in the growing global market of clinical trial services.
Sanofi, which already has messenger RNA R&D alliances with other companies, paid $160 million up front to acquire preclinical startup Tidal Therapeutics. The pharma giant said Tidal’s mRNA approach could lead to an off-the-shelf CAR-T therapy.
Mobidiag offers multiplex testing, which is the ability to test for multiple pathogens from a single test sample. Hologic said the acquisition will enable the company to enter the acute care test market, which is projected to grow in a post-pandemic world.
IQVIA has acquired Quest Diagnostics’ minority stake in Q2 Solutions, a central laboratory services joint venture the two companies formed in 2015. But Quest will remain a preferred provider of lab testing services under an agreement with Q2.
After a busy year, at-home testing company Everlywell is growing through two acquisitions. It bought telehealth practice PWNHealth and another at-home lab testing company.
In another big tie-up between a telehealth and digital health company, Grand Rounds and Doctor on Demand reached a merger agreement. Grand Rounds CEO Owen Tripp will serve as CEO of the combined business.
Roche already sells a Covid-19 diagnostic. In acquiring GenMark Diagnostics for $1.8B, Roche is adding technology that can detect SARS-CoV-2 along with multiple respiratory diseases in a single test from a single patient sample—a capability the Swiss multinational company does not currently offer.
The digital physical therapy company acquired a startup making a small, adhesive device that use electrical pulses for pain treatment.
ICON executives say technology is a key factor in the $12 billion acquisition. PRA Health Sciences has a mobile health platform that enables patients to participate in clinical trials from their homes.
Hillrom will buy Bardy Diagnostics, a startup that makes a wearable ECG patch, for $375 million in cash.
Britain’s biggest drugmaker offers 45% premium for shares of US rare diseases specialist AstraZeneca shares fell sharply after it agreed to a $39bn (£29bn) takeover of the US rare diseases specialist Alexion, the biggest deal in its history if it goes ahead. Investors sold off shares in the Anglo-Swedish drugmaker over fears it was paying …
ABITEC, an ABF Ingredients company, announced on July 8, 2020 that it has acquired Larodan AB, a Sweden-based manufacturer and international marketer of high-purity research grade lipids, to expand its lipid product offerings and scientific capabilities. Through the acquisition, the compan
Legislation protects those needed in future pandemics who may be struggling now Coronavirus – latest updates See all our coronavirus coverage The UK government has introduced legislation to protect businesses that are key to public health from foreign takeovers. The changes give the government the power to protect companies that could be critical in helping …